Lyka Labs (NSE:LYKALABS) Total Stockholders Equity : ₹1,036 Mil (As of Mar. 2025)

View and export this data going back to 1995. Start your Free Trial

What is Lyka Labs Total Stockholders Equity?

Lyka Labs's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ₹1,036 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Lyka Labs's Book Value per Share for the quarter that ended in Mar. 2025 was ₹28.16. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Lyka Labs's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.38.

Lyka Labs Total Stockholders Equity Historical Data

The historical data trend for Lyka Labs's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lyka Labs Total Stockholders Equity Chart

Lyka Labs Annual Data

Trend

Jun15

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Total Stockholders Equity

Get a 7-Day Free Trial

-257.97

133.39

454.41

681.54

1,035.50

Lyka Labs Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															681.54	-	989.11	-	1,035.50

Lyka Labs (NSE:LYKALABS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Lyka Labs's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1035.502	-	0)	/	36.767
	=	28.16

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Lyka Labs's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(192.85	+	198.989)	/	1035.502
	=	0.38

Lyka Labs Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Lyka Labs's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Lyka Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lyka Labs Ltd (NSE:LYKALABS) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

500259:India

Address

30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Grant Road (West), Mumbai, MH, IND, 400036

Website

http://www.lykalabs.com

Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment which is pharmaceuticals. The Company has a presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.

Lyka Labs Headlines

No Headlines